These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28977508)

  • 1. Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides.
    Bailey JK; Shen W; Liang XH; Crooke ST
    Nucleic Acids Res; 2017 Oct; 45(18):10649-10671. PubMed ID: 28977508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
    Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
    Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.
    Zhang L; Vickers TA; Sun H; Liang XH; Crooke ST
    Nucleic Acids Res; 2021 Mar; 49(5):2721-2739. PubMed ID: 33577678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation of ALS-linked FUS mutant sequesters RNA binding proteins and impairs RNA granules formation.
    Takanashi K; Yamaguchi A
    Biochem Biophys Res Commun; 2014 Sep; 452(3):600-7. PubMed ID: 25173930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.
    Shen W; De Hoyos CL; Sun H; Vickers TA; Liang XH; Crooke ST
    Nucleic Acids Res; 2018 Mar; 46(5):2204-2217. PubMed ID: 29390093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells.
    Liang XH; Shen W; Sun H; Prakash TP; Crooke ST
    Nucleic Acids Res; 2014 Jul; 42(12):7819-32. PubMed ID: 24861627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2'-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF.
    Shen W; Liang XH; Sun H; Crooke ST
    Nucleic Acids Res; 2015 May; 43(9):4569-78. PubMed ID: 25855809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of 2'-ribose unmodified and modified phosphorothioate oligonucleotide therapeutics using liquid chromatography mass spectrometry.
    Kim J; El Zahar NM; Bartlett MG
    Biomed Chromatogr; 2020 Jul; 34(7):e4839. PubMed ID: 32246854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor.
    Schmidt K; Prakash TP; Donner AJ; Kinberger GA; Gaus HJ; Low A; Østergaard ME; Bell M; Swayze EE; Seth PP
    Nucleic Acids Res; 2017 Mar; 45(5):2294-2306. PubMed ID: 28158620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides.
    Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
    Nucleic Acids Res; 2017 May; 45(9):5309-5322. PubMed ID: 28379543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of PRMT1-mediated arginine methylation on the subcellular localization, stress granules, and detergent-insoluble aggregates of FUS/TLS.
    Yamaguchi A; Kitajo K
    PLoS One; 2012; 7(11):e49267. PubMed ID: 23152885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorothioate modified oligonucleotide-protein interactions.
    Crooke ST; Vickers TA; Liang XH
    Nucleic Acids Res; 2020 Jun; 48(10):5235-5253. PubMed ID: 32356888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-Phase Separation of Toxic Phosphorothioate Antisense Oligonucleotide-Protein Nucleolar Aggregates Is Cytoprotective.
    Liang XH; De Hoyos CL; Shen W; Zhang L; Fazio M; Crooke ST
    Nucleic Acid Ther; 2021 Apr; 31(2):126-144. PubMed ID: 33534636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorothioate oligonucleotides can displace NEAT1 RNA and form nuclear paraspeckle-like structures.
    Shen W; Liang XH; Crooke ST
    Nucleic Acids Res; 2014 Jul; 42(13):8648-62. PubMed ID: 25013176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
    Shen W; De Hoyos CL; Migawa MT; Vickers TA; Sun H; Low A; Bell TA; Rahdar M; Mukhopadhyay S; Hart CE; Bell M; Riney S; Murray SF; Greenlee S; Crooke RM; Liang XH; Seth PP; Crooke ST
    Nat Biotechnol; 2019 Jun; 37(6):640-650. PubMed ID: 31036929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorothioate Antisense Oligonucleotides Bind P-Body Proteins and Mediate P-Body Assembly.
    Wang Y; Shen W; Liang XH; Crooke ST
    Nucleic Acid Ther; 2019 Dec; 29(6):343-358. PubMed ID: 31429620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1.
    Vickers TA; Rahdar M; Prakash TP; Crooke ST
    Nucleic Acids Res; 2019 Nov; 47(20):10865-10880. PubMed ID: 31495875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
    Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
    Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.
    Liang XH; Sun H; Shen W; Crooke ST
    Nucleic Acids Res; 2015 Mar; 43(5):2927-45. PubMed ID: 25712094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides.
    Wang S; Allen N; Vickers TA; Revenko AS; Sun H; Liang XH; Crooke ST
    Nucleic Acids Res; 2018 Apr; 46(7):3579-3594. PubMed ID: 29514240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.